Health Affairs August 25, 2021
Editor’s Note
This post is part of the Health Affairs Blog short series, “Envisioning A Transformed Clinical Trials Enterprise For 2030.” The series explores ideas for advancing a clinical trials enterprise that is more efficient, effective, person-centered, inclusive, and integrated into the health delivery system of 2030 than is currently the case. The series is being published in conjunction with a four-part public workshop, Envisioning a Transformed Clinical Trials Enterprise in 2030, convened under the auspices of the National Academies Forum on Drug Discovery, Development, and Translation. Posts in this series are published by Health Affairs Blog with the support of the National Academies, but they represent the opinions of the authors and do not necessarily represent the views of...